Vir Biotechnology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $1.40B
Liabilities Breakdown FY2024
Total Liabilities: $248.4M
Asset Breakdown
Total Assets: $1.40B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $222.9M | 15.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $63.2M | 4.5% |
| Goodwill | $16.9M | 1.2% |
| Intangible Assets | $8.1M | 0.6% |
| Other Assets | $1.09B | 77.8% |
Liabilities Breakdown
Total Liabilities: $248.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.1M | 2.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $243.3M | 98.0% |